HD-OPM Archive
Topics › Lp(a)

Adding Lp(a) did not improve AHA PREVENT risk prediction, foreshadowing Lp(a)HORIZON

Louis Nervegna · Nov 08, 2026 · ♥ 3 reactions · 3 comments · original Facebook post
Lp(a)Risk assessment & lab tests
↻ This is a repost. The main version (highest ranked) is Adding Lp(a) does not improve PREVENT 10-year risk prediction, but personalizes risk · Aug 16, 2025.
AI summary & key facts

Louis argues the Lp(a)HORIZON result was foreshadowed because adding Lp(a) to the AHA PREVENT 10-year risk equations did not improve accuracy, implying Lp(a) is not independent of traditional risk factors. A person with optimized traditional factors may gain nothing from lowering Lp(a). The JAMA Cardiology editorial adds that measuring Lp(a) can still personalize risk.

Did the newest AHA risk calculator predict the Lp(a) HORIZON trial would fail?
You can make the case that it did.

The accuracy of the American Heart Association calculator for predicting 10 year risk is not improved by adding Lp(a).

The researchers who developed the mathematical model behind this calculator spent a good deal of time trying to incorporate Lp(a) into the calculator.

However, they found that adding Lp(a) made no difference. The calculator was just as good at predicting risk, whether Lp(a) was included or not.

This surprising finding hinted that Lp(a) was not truly independent of the traditional risk factors previously included in the calculator.

According to the calculator, a person who has already optimized all of their traditional risk factors will see no added benefit from lowering Lp(a). This is exactly what happened in the HORIZON trial.

Quoted:

“In parallel with improvements in risk scores, there has been an unending search for blood-based biomarkers that may add predictive utility to existing risk equations. Many such biomarkers have demonstrated independent associations with ASCVD events, but have fallen short with regard to demonstrating incremental predictive utility, precluding recommendations for universal screening or routine incorporation into risk equation platforms.”

“In this issue of JAMA Cardiology, Bhatia et al evaluate the predictive utility of adding lipoprotein(a) (Lp[a]) level, a blood-based biomarker consistently linked to ASCVD risk, to the PREVENT equations.”

“With regard to predictive utility, Lp(a) did not change C statistics significantly and it had very modest ability to reclassify predicted risk appropriately, as evidenced by the continuous and categorical net reclassification improvements.”

#lpaHD #calculatorHD #ahaHD #preventHD #horizonHD #pelacarsenHD

Research cited

Editorial: The PREVENT equations enhance cardiovascular risk assessment, and while adding lipoprotein(a) doesn't improve prediction, measuring it can personalize risk due to its role as a causal factor. AHA PREVENT Equations With Lipoprotein(a) and Risk Assessment for Primary Prevention (JAMA Cardiol, 2025)

No photo description available.
← newer: B12 lowers homocysteine but has not cut heart attacks; B vitolder: Countries with the lowest milk intake have the lowest fractu →